An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial

The Cordimax stent has proved non-inferior to the Cypher Select durable polymer sirolimus-eluting stent for the primary endpoint of angiographic in-stent late luminal loss and in-stent mean diameter stenosis at 9 months. The trial was designed to compare the efficacy and safety of the Cordimax stent...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haijun, Zhang, Xiaoping, Yin, Yuxia, Zhou, Chao, Deng, Wei, Zhang, Junwei, Hou, Wenbo, Lu, Shoutao, Song, Caixia, Cui, Xiaoshan, Wang, Shenguo, Yang, Fei, Liu, Guang, Duan, Cuihai, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898363/
https://www.ncbi.nlm.nih.gov/pubmed/31811206
http://dx.doi.org/10.1038/s41598-019-54964-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898363/
https://www.ncbi.nlm.nih.gov/pubmed/31811206
http://dx.doi.org/10.1038/s41598-019-54964-8

Ejemplares similares